drugset / Trial / NCT00799968

12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China

NCT00799968

Phase 4 Completed 129 enrolled Beijing Chao Yang Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Comparative trials of urokinase (UK) for 12 hours(UK-12h)or 24 hours (UK-24h) have produced similar results in acute pulmonary thromboembolism (PTE) thrombolysis. It is unclear whether the infusion time can be reduced further. The aim of this study was to investigate the efficacy and safety of weight adjusted dosage of UK-2h (20 000 IU/Kg) regime with the Uk-12h regime in selected patients with PTE in Chinese population.

Timeline

Start
2002-06
Primary completion
2006-02
Completion
2006-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Urokinase Protein / enzyme biologic 2200 iu/kg Intravenous
Subject Urokinase Protein / enzyme biologic 20000 iu/kg Intravenous